Eslicarbazepine acetate

Details

Files

Generic Name:

Eslicarbazepine acetate

Project Status:

Complete

Therapeutic Area:

Epilepsy, partial-onset seizures

Manufacturer:

Sunovion Pharmaceuticals Canada Inc.

Call for patient/clinician input open:

July 17, 2014

Brand Name:

Aptiom

Project Line:

Reimbursement Review

Project Number:

SR0391-000

Call for patient/clinician input closed:

September 8, 2014

NOC Status at Filing:

Post NOC

Submission Type:

Initial

Indications:

Epilepsy, partial-onset seizures

Recommendation Type:

List with criteria/condition

Final Recommendation:

April 16, 2015

Files

Submission Status Report View PDF

Recommendation and Reasons View PDF

Clinical Report View PDF

Pharmacoeconomic Report View PDF

Patient Group Input Submissions View PDF

Last Updated : August 15, 2014